Twist Other Liab from 2010 to 2024

TWST Stock  USD 43.62  0.99  2.22%   
Twist Bioscience Other Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Liabilities will likely drop to about 65.5 K in 2024. From the period from 2010 to 2024, Twist Bioscience Other Liabilities quarterly data regression had r-value of  0.16 and coefficient of variation of  262.87. View All Fundamentals
 
Other Liabilities  
First Reported
2016-09-30
Previous Quarter
60 K
Current Value
60 K
Quarterly Volatility
4.6 M
 
Covid
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
Check out the analysis of Twist Bioscience Correlation against competitors.

Latest Twist Bioscience's Other Liab Growth Pattern

Below is the plot of the Other Liab of Twist Bioscience Corp over the last few years. It is Twist Bioscience's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Pretty Stable
   Other Liab   
       Timeline  

Twist Other Liab Regression Statistics

Arithmetic Mean483,637
Geometric Mean170,701
Coefficient Of Variation262.87
Mean Deviation611,248
Median162,000
Standard Deviation1,271,325
Sample Variance1.6T
Range5M
R-Value0.16
Mean Square Error1.7T
R-Squared0.03
Significance0.56
Slope46,414
Total Sum of Squares22.6T

Twist Other Liab History

202465.5 K
202369 K
202160 K
20205.1 M
2019351 K
2018158 K
2017344 K

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as Other Liab, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities69 K65.5 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.